Events

Melphalan and High Dose IV Vitamin C for Multiple Myeloma with Yogesh Jethava, MD, University of Iowa

A New CD38 Monocloncal Antibody Called Isatuximab Gets Closer to the Clinic, with Ravi Vij, MD, Washington University

Myeloma Progress in 2018 and a Look to the Future in Multiple Myeloma with Dr. Robert Z. Orlowski, MD Anderson Cancer Center

Personalized Myeloma Treatment Using 3D Tumor Modeling

Identifying and Killing Myeloma Cells That Cause Myeloma and Relapse with MCRI Award Winner Dr. Frank Zhan and Dr. Yogesh Jethava

Creating an Immune System Signature to Gauge Myeloma Risk with MCRI Award Winner David Chung, MD, MSKCC

Buffalo Round Table - November 10, 2018

Creating Your Most Valuable Plan (MVP) in Multiple Myeloma with David Winfield and Don Baylor Jr.

Scottsdale Round Table - October 14, 2018
